Chinese Journal of Dermatology ›› 2018, Vol. 51 ›› Issue (5): 396-399.doi: 10.3760/cma.j.issn.0412-4030.2018.05.023
,Yue-ping YIN,
Received:2017-11-02
Revised:2017-11-24
Online:2018-05-15
Published:2018-05-02
Contact:
Yue-ping YIN
E-mail:yinyp@ncstdlc.org
Yue-ping YIN. Comparison of guidelines for antibiotic treatment of uncomplicated gonorrhea[J].Chinese Journal of Dermatology, 2018, 51(5): 396-399.
| ［1］ | 蒋朱明, 詹思延, 贾晓巍, 等. 制订/修订《临床诊疗指南》的基本方法及程序［J］. 中华医学杂志, 2016,96（4）:250⁃253. doi: 10.3760/cma.j.issn.0376⁃2491.2016.04.004.<br /> |
| ［2］ | Newman L, Rowley J, Vander HS, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting［J］. PLoS One, 2015,10（12）:e0143304. doi: 10.1371/journal.pone. 0143304.<br /> |
| ［3］ | Skerlev M, Culav⁃Košcak I. Gonorrhea: new challenges［J］. Clin Dermatol, 2014,32（2）:275⁃281. doi: 10.1016/j.clindermatol.2013. 08.010.<br /> |
| ［4］ | Papp JR, Abrams AJ, Nash E, et al. Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA［J］. Emerg Infect Dis, 2017,23（5）:830⁃832. doi: 10.3201/eid2305.170088.<br /> |
| ［5］ | Lahra MM, Enriquez RP, National Neisseria Network. Prince of Wales Hospital, Randwick, for The National Neisseria Network. Australian gonococcal surveil⁃lance programme, 1 July to 30 September 2016［J］. Commun Dis Intell Q Rep, 2017,41（1）:E109⁃E110.<br /> |
| ［6］ | Yasuda M, Hatazaki K, Ito S, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015［J］. Sex Transm Dis, 2017,44（3）:149⁃153. doi: 10.1097/OLQ.0000000000000556.<br /> |
| ［7］ | Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone⁃resistant Neisseria gonorrhoeae, Japan［J］. Emerg Infect Dis, 2011,17（1）:148⁃149. doi: 10.3201/eid1701.100397.<br /> |
| ［8］ | Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high⁃level resistance to ceftriaxone［J］. Antimicrob Agents Chemother, 2011,55（7）:3538⁃3545. doi: 10.1128/AAC.00325⁃11.<br /> |
| ［9］ | World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae［EB/OL］. （2012）［2017⁃10⁃10］. http://apps.who.int/iris/bitstream/handle/10665/44863/9789241503501_eng.pdf; jse<br /> |
| ssionid=328FFA0906F2F0799A827B764DAC7BEB?sequence=<br /> | |
| 1. | <br /> |
| ［10］ | Japanese Society for Sexually Transmitted Diseases. Guidelines for the diagnosis and treatment of sexually transmitted diseases 2011［J］. Jpn J Sex Transm Dis, 2011,22Suppl: 52⁃59.<br /> |
| ［11］ | Japanese Society for Sexually Transmitted Diseases. Guidelines for the diagnosis and treatment of sexually transmitted diseases 2016［J］. Jpn J Sex Transm Dis, 2016, 22Suppl: 51⁃58.<br /> |
| ［12］ | Bignell C, Fitzgerald M. UK national guideline for the manage⁃ment of gonorrhoea in adults, 2011［J］. Int J STD AIDS, 2011,22（10）:541⁃547. doi: 10.1258/ijsa.2011.011267.<br /> |
| ［13］ | Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults［J］. Int J STD AIDS, 2013,24（2）:85⁃92. doi: 10.1177/0956462412472837.<br /> |
| ［14］ | Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections［EB/OL］. （2013⁃7）［2017⁃10⁃10］. https://www.canada.ca/en/public⁃health/services/infectious⁃diseases/sexual⁃health⁃sexually⁃transmitted⁃infections/canadian⁃guidelines/sexually⁃transmitted⁃infections/canadian⁃guidelines⁃sexually⁃transmitted⁃infections⁃34.html.<br /> |
| ［15］ | The New Zealand Sexual Health Society. New Zealand guideline for the management of gonorrhoea, 2014, and response to the threat of antimicrobial resistance. 2014. http://www.regionalnet⁃work.ashm.org.au/wp⁃content/uploads/2016/04/new⁃zealand⁃guideline⁃for⁃the⁃management⁃of⁃gonorrhoea⁃2014⁃and⁃response⁃to⁃the⁃threat⁃of⁃antimicrobial⁃resistance.pdf.<br /> |
| ［16］ | Workowski KA, Bolan GA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines. 2015［J］. MMWR Recomm Rep, 2015,64（RR⁃03）:1⁃137.<br /> |
| ［17］ | Australasian Sexual Health Alliance. Australian STI management guidelines for use in primary care. 2016. http://www.sti.guidelines.org.au/ sexually⁃transmissible⁃infections/ gonorrhoea#management. （assess in Oct 10, 2017）<br /> |
| ［18］ | 中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南（2014）［J］. 中华皮肤科杂志, 2014,47（5）:365⁃372. doi: 10.3760/cma.j.issn.0412⁃4030.2014.05.022.<br /> |
| ［19］ | World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. https://www.ncbi.nlm.nih.gov/pubmedhealth/ PMH0093492/.<br /> |
| ［20］ | Newman LM, Moran JS, Workowski KA. Update on the manage⁃ment of gonorrhea in adults in the United States［J］. Clin Infect Dis, 2007,44（Suppl 3）:S84⁃101. doi: 10.1086/511422<br /> |
| ［21］ | Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?［J］. J Antimicrob Chemother, 2010,65（10）:2141⁃2148. doi: 10.1093/jac/dkq289.<br /> |
| ［22］ | 于瑞星, 尹跃平, 戴秀芹, 等. 头孢曲松和阿奇霉素体外抗淋球菌联合作用研究［J］. 中华皮肤科杂志, 2017,50（5）:364⁃366. doi: 10.3760/cma.j.issn.0412⁃4030.2017.05.012.<br /> |
| ［23］ | Sathia L, Ellis B, Phillip S, et al. Pharyngeal gonorrhoea ⁃ is dual therapy the way forward?［J］. Int J STD AIDS, 2007,18（9）:647⁃648. doi: 10.1258/095646207781568556.<br /> |
| [1] | Liang Yuan, Liu Lingling, Wang Shan, Zhao Zuotao, Ma Lin, Xiang Xin, Gu Heng, Chen Kun, Wang Hua, Yi Hong, Chen Jinping, Zhang Jintao, Yao Zhirong, Guo Yifeng, Chen Ji, Cheng Ying, Zhu Xuejun. Efficacy and safety of 0.03% tacrolimus ointment in the long-term intermittent maintenance treatment of atopic dermatitis in children: a multicenter randomized controlled clinical trial [J]. Chinese Journal of Dermatology, 2019, 52(8): 519-524. |
| [2] | Lu Tan, Wang Shan, Wang Liuhui, Li Ping, Shu Hong, Shen Chunping, Wu Yao, Luo Zhen, Miao Limin, Wang Hongbing, Jiao Lei, Tian Jing, Peng Xiaoxia, Zhao Mutong, Liu Ying, Nie Xiaolu, Ma Lin, He Li. An emollient containing Prinsepia utilis Royle oil extracts and other extracts for the improvement of clinical symptoms among children aged 2 - 12 years with atopic dermatitis in the remission period: a multicenter, randomized, parallel-group, controlled clinical study [J]. Chinese Journal of Dermatology, 2019, 52(8): 537-541. |
| [3] | Zhou Yuan, Chen Wei, Wang Daguang. Treatment of pincer nails [J]. Chinese Journal of Dermatology, 2019, 52(5): 364-367. |
| [4] | Yu Lijuan, Lyu Zhongfa. JAK inhibitors for the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2019, 52(5): 343-346. |
| [5] | Lei Jiehao, Fan Qimin, Chen Rong, Xu Ai′e. Association between efficacy of and response to narrow-band ultraviolet B phototherapy as well as factors related to phototherapy response in patients with vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 259-262. |
| [6] | Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2018 simplified edition） [J]. Chinese Journal of Dermatology, 2019, 52(4): 223-230. |
| [7] | Liu Zijing, Wang Xiaoyan, Juliandri, Zhang Jiawen, Xu Yang. Non-surgical lipolysis techniques [J]. Chinese Journal of Dermatology, 2019, 52(4): 290-294. |
| [8] | Centre for Lupus Erythematosus Research, Chinese Society of Dermatology. Guideline for diagnosis and treatment of cutaneous lupus erythematosus （2019） [J]. Chinese Journal of Dermatology, 2019, 52(3): 149-155. |
| [9] | Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161. |
| [10] | Zhai Hanyue, Song Yixing. Childhood molluscum contagiosum treated with 585 nm pulsed dye laser: a clinical observation [J]. Chinese Journal of Dermatology, 2019, 52(3): 195-197. |
| [11] | Guan Xin, Zhang Chunlei. Evaluation of efficacy of infliximab in the long-term treatment of moderate and severe psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2019, 52(2): 86-89. |
| [12] | Yu Yixin, Yang Bin. A review of Chinese and foreign guidelines for the diagnosis and treatment of hand eczema [J]. Chinese Journal of Dermatology, 2019, 52(1): 53-56. |
| [13] | Centre for Urticaria Research, Chinese Society of Dermatology. Guideline for diagnosis and treatment of urticaria in China （2018） [J]. Chinese Journal of Dermatology, 2019, 52(1): 1-5. |
| [14] | Yue-Tong QIAN Dong-Lai MA. Application of Janus kinase inhibitors in dermatology [J]. Chinese Journal of Dermatology, 2018, 51(9): 704-707. |
| [15] | . Evaluation of efficacy of microneedling radiofrequency for the treatment of facial acne scars [J]. Chinese Journal of Dermatology, 2018, 51(9): 672-675. |
|
